Joëlle Collignon

2.7k total citations
59 papers, 699 citations indexed

About

Joëlle Collignon is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joëlle Collignon has authored 59 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in Joëlle Collignon's work include Cancer Treatment and Pharmacology (14 papers), HER2/EGFR in Cancer Research (11 papers) and Breast Cancer Treatment Studies (9 papers). Joëlle Collignon is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), HER2/EGFR in Cancer Research (11 papers) and Breast Cancer Treatment Studies (9 papers). Joëlle Collignon collaborates with scholars based in Belgium, Germany and Denmark. Joëlle Collignon's co-authors include Guy Jérusalem, Laurence Lousberg, Hélène Schroeder, Andrée Rorive, Dominic P. Norris, Isabelle Varlet, Elizabeth J. Robertson, Pierre Frères, Stéphane Wenric and Claire Josse and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Joëlle Collignon

48 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joëlle Collignon Belgium 12 383 285 257 127 52 59 699
Nina Gottschalk Germany 9 280 0.7× 409 1.4× 268 1.0× 145 1.1× 69 1.3× 23 725
Hae Hyun Jung South Korea 18 378 1.0× 293 1.0× 330 1.3× 161 1.3× 47 0.9× 30 772
Corine M. Beaufort Netherlands 10 314 0.8× 259 0.9× 279 1.1× 134 1.1× 32 0.6× 24 608
Caiwen Du China 15 473 1.2× 416 1.5× 250 1.0× 168 1.3× 40 0.8× 45 803
Kay T. Yeung United States 10 557 1.5× 299 1.0× 264 1.0× 94 0.7× 46 0.9× 19 848
Denis Alférez United Kingdom 12 340 0.9× 300 1.1× 127 0.5× 86 0.7× 52 1.0× 17 551
Daniela Frezzetti Italy 13 358 0.9× 175 0.6× 266 1.0× 110 0.9× 27 0.5× 18 613
Kang‐Lai Wei China 13 441 1.2× 202 0.7× 325 1.3× 148 1.2× 37 0.7× 27 680
Hend Ahmed El-Hadaad Egypt 9 241 0.6× 243 0.9× 140 0.5× 105 0.8× 38 0.7× 25 552
Guoxian Long China 15 289 0.8× 291 1.0× 217 0.8× 108 0.9× 20 0.4× 35 661

Countries citing papers authored by Joëlle Collignon

Since Specialization
Citations

This map shows the geographic impact of Joëlle Collignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joëlle Collignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joëlle Collignon more than expected).

Fields of papers citing papers by Joëlle Collignon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joëlle Collignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joëlle Collignon. The network helps show where Joëlle Collignon may publish in the future.

Co-authorship network of co-authors of Joëlle Collignon

This figure shows the co-authorship network connecting the top 25 collaborators of Joëlle Collignon. A scholar is included among the top collaborators of Joëlle Collignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joëlle Collignon. Joëlle Collignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pottier, Charles, Dominique Baiwir, Gabriel Mazzucchelli, et al.. (2025). Targeting ferroptosis resistance resensitizes metastatic HR + HER2 − breast cancer cells to palbociclib‐hormone therapy. Cancer Communications. 45(4). 460–464. 1 indexed citations
2.
Segers, Karin, Pascal Wolter, Joëlle Collignon, et al.. (2024). Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients. Journal of Personalized Medicine. 14(6). 584–584.
3.
Cutsem, Eric Van, Joëlle Collignon, Rikke Løvendahl Eefsen, et al.. (2024). Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer. Clinical Cancer Research. 30(23). 5293–5303. 2 indexed citations
4.
5.
Joris, Sofie, Hannelore Denys, Joëlle Collignon, et al.. (2023). Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. ESMO Open. 8(6). 102041–102041. 18 indexed citations
6.
7.
Decoster, Lore, Philippe Aftimos, Sylvie Rottey, et al.. (2023). 201P Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study. Annals of Oncology. 34. S262–S262. 1 indexed citations
8.
Detry, Olivier, et al.. (2021). Prise en charge multidisciplinaire des tumeurs malignes primitives du foie.. RMLG. Revue médicale de Liège. 76.
9.
Onesti, Concetta Elisa, Hélène Schroeder, Andrée Rorive, et al.. (2020). 1712P Risk of SARS-CoV-2 infection and outcome after infection: Experience from the day-care unit at CHU Liège in Belgium. Annals of Oncology. 31. S1007–S1007.
10.
Onesti, Concetta Elisa, Hélène Schroeder, Andrée Rorive, et al.. (2020). 1720P How do oncological patients perceive the COVID-19 pandemic? Experience from CHU Liège in Belgium. Annals of Oncology. 31. S1010–S1010. 1 indexed citations
11.
Lousberg, Laurence, Joëlle Collignon, & Olivier Detry. (2019). Appendiceal neuroendrocrine neoplasms. Current Opinion in Gastroenterology. 36(1). 48–54. 3 indexed citations
12.
Foidart, Pierre, Silvia Blacher, Erik Maquoi, et al.. (2018). Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy. Clinical Cancer Research. 25(6). 1838–1850. 41 indexed citations
13.
Collignon, Joëlle, et al.. (2016). Le carcinome de site primitif inconnu, une entité pas si rare .... RMLG. Revue médicale de Liège. 71(10).
14.
Frères, Pierre, Stéphane Wenric, Corinne Fasquelle, et al.. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. 7(5). 5416–5428. 49 indexed citations
15.
Paye, Alexandra, Jonathan Cimino, Silvia Blacher, et al.. (2014). EGFR Activation and Signaling in Cancer Cells Are Enhanced by the Membrane-Bound Metalloprotease MT4-MMP. Cancer Research. 74(23). 6758–6770. 34 indexed citations
16.
Jérusalem, Guy, Andrée Rorive, & Joëlle Collignon. (2014). [The drug of the month: everolimus (Afinitor) for the treatment of metastatic breast cancer].. PubMed. 69(9). 510–7. 2 indexed citations
17.
Jérusalem, Guy, Andrée Rorive, & Joëlle Collignon. (2014). Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes. SHILAP Revista de lepidopterología. 8 indexed citations
18.
Collignon, Joëlle & Guy Jérusalem. (2012). [Will targeted therapies replace chemotherapy?].. PubMed. 67 Spec No. 29–36. 1 indexed citations
19.
Collignon, Joëlle, Christine Gennigens, & G. Jerusalem. (2010). Assessment of Response to Therapy for Bone Metastases: Is it Still a Challenge in Oncology?. PET Clinics. 5(3). 311–326. 2 indexed citations
20.
Collignon, Joëlle, et al.. (1994). Rapid Diagnosis of Cerebral Toxoplasmosis By Pcr in Allogeneic Bmt Leads To Early and Successful Treatment. Blood. 84(10).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Gottschalk Breakdown of academic impact, for papers by Hae Hyun Jung Breakdown of academic impact, for papers by Corine M. Beaufort Breakdown of academic impact, for papers by Caiwen Du Breakdown of academic impact, for papers by Kay T. Yeung Breakdown of academic impact, for papers by Denis Alférez Breakdown of academic impact, for papers by Daniela Frezzetti Breakdown of academic impact, for papers by Kang‐Lai Wei Breakdown of academic impact, for papers by Hend Ahmed El-Hadaad Breakdown of academic impact, for papers by Guoxian Long
Rankless by CCL
2026